Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitis

被引：0
作者：
van Der Rijst, Lisa P. [1 ,2 ]
Veldhuis, Nienke [2 ]
van Der Kamp, Sara [2 ]
Achten, Roselie E. [2 ]
van Luijk, Chantal M. [3 ]
Voskuil-Kerkhof, Elsbeth S. M. [3 ]
Haeck, Inge M. [2 ]
de Bruin-Weller, Marjolein S. [2 ]
de Graaf, Marlies [1 ,2 ]
机构：
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Dept Dermatol & Allergol,Wilhelmina Childrens Hosp, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Natl Expertise Ctr Atop Dermatitis, Dept Dermatol & Allergol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
来源：
PEDIATRIC ALLERGY AND IMMUNOLOGY | 2025年 / 36卷 / 02期
关键词：
atopic dermatitis; children; conjunctivitis; ocular surface disease; pediatric; type; 2; inflammation; CHILDREN;
D O I：
10.1111/pai.70040
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Management of Severe Atopic Dermatitis in Pediatric Patients
    Mancuso, Jennifer B.
    Lee, Stephanie S.
    Paller, Amy S.
    Ohya, Yukihiro
    Eichenfield, Lawrence F.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (04) : 1462 - 1471
  • [22] Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab
    Martinez-Cabriales, Sylvia
    Marcoux, Danielle
    Liy-Wong, Carmen
    Prajapati, Vimal H.
    Sibbald, Cathryn
    Cunningham, Natalie
    Lansang, Perla
    Tonkin, Rochelle
    Joseph, Marissa
    Wong, Lauren
    Spring, Shanna
    Gavigan, Genevieve
    Ramien, Michele
    PEDIATRIC DERMATOLOGY, 2024, 41 (01) : 5 - 11
  • [23] Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Facheris, Paola
    Gomez-Arias, Pedro Jesus
    Del Duca, Ester
    Da Rosa, Joel Correa
    Weidinger, Stephan
    Bissonnette, Robert
    Armstrong, April W.
    Seneschal, Julien
    Eyerich, Kilian
    Estrada, Yeriel D.
    Bose, Swaroop N.
    Xu, Dan
    Chen, Allshine
    Tatulych, Svitlana
    Guler, Erman
    Chan, Gary
    Page, Karen M.
    Kerkmann, Urs
    ALLERGY, 2024, 79 (05) : 1258 - 1270
  • [24] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
  • [25] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
    Murase, Jenny E.
    Chovatiya, Raj
    Strowd, Lindsay
    Thyssen, Jacob P.
    Bangert, Christine
    Atwater, Amber Reck
    Gallo, Gaia
    Bardolet, Laia
    Yang, Fan
    Zhong, Jinglin
    Staumont-Salle, Delphine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [26] Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
    Zhou, Lisa
    Leonard, Alexandra
    Pavel, Ana B.
    Malik, Kunal
    Raja, Aishwarya
    Glickman, Jacob
    Estrada, Yeriel D.
    Peng, Xiangyu
    del Duca, Ester
    Sanz-Cabanillas, Juan
    Ruano, Juan
    Xu, Hui
    Zhang, Ning
    Wen, Huei-Chi
    Gonzalez, Juana
    Garcet, Sandra
    Krueger, James G.
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (01) : 144 - 156
  • [27] Dupilumab-Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single-Center Asian Experience
    Yap, Amanda Xin Yi
    Tan, Deborah
    Koh, Mark Jean-Aan
    Yang, Lin Yi
    Zhe, Koh Yi
    Wee, Lynette Wei-Yi
    PEDIATRIC DERMATOLOGY, 2024,
  • [28] Is antibiotics prescription needed in infants with topical corticosteroids treatment for moderate-to-severe atopic dermatitis?
    Liu, Ying
    Zhou, Qian
    Dai, Wenkui
    Wang, Shan
    Liang, Yuan
    Li, Yinhu
    Shen, Chunping
    Li, Dongfang
    Li, Yunzhu
    Jiao, Lei
    Bian, Yawei
    Li, Shuaicheng
    Tang, Yi-Wei
    Ma, Lin
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [29] Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan D.
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing
    Lima, Renata Gontijo
    Pillai, Sreekumar G.
    Seneschal, Julien
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12) : 1080 - 1091
  • [30] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
12345